PLIN5 and metabolic dysfunction-associated steatotic liver disease: This is consistent with the function played by PLIN5 in non-alcoholic fatty liver disease (NAFLD) liver disease [51], specifically overexpression of PLIN5 in activated HSCs inhibition of cell proliferation, and a significant increase in cell apoptosis.